您的购物车当前为空
Niclosamide 是一种经典的水杨酰胺类(salicylanilide)抗寄生虫药物,是一种多靶点、低毒性的广谱小分子调节剂,具有驱虫、抗肿瘤活性。Niclosamide 通过解偶联线粒体氧化磷酸化,破坏寄生虫能量代谢,导致 ATP 生成减少,从而杀灭寄生虫。Niclosamide 是 STAT3 抑制剂,在 HeLa 细胞中的 IC50 为 0.25 μM。
别名 氯硝柳胺, Niclocide, BAY2353
Niclosamide 是一种经典的水杨酰胺类(salicylanilide)抗寄生虫药物,是一种多靶点、低毒性的广谱小分子调节剂,具有驱虫、抗肿瘤活性。Niclosamide 通过解偶联线粒体氧化磷酸化,破坏寄生虫能量代谢,导致 ATP 生成减少,从而杀灭寄生虫。Niclosamide 是 STAT3 抑制剂,在 HeLa 细胞中的 IC50 为 0.25 μM。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 500 mg | ¥ 320 | 现货 | |
| 5 g | ¥ 413 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 150 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Niclosamide is a classic salicylanilide antiparasitic drug and a multi-target, low-toxicity, broad-spectrum small-molecule modulator with anthelmintic and antitumor activity. Niclosamide disrupts the parasite’s energy metabolism by uncoupling mitochondrial oxidative phosphorylation, leading to reduced ATP production and ultimately killing the parasite. Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells. |
| 靶点活性 | STAT3:0.7 μM |
| 体外活性 | 方法:从 MDA-MB-231 细胞中分离的 CD44⁺/CD24⁻ 乳腺癌干细胞(CSCs)加入 Niclosamide (100 μM),处理 6 小时,Western blot 检测 p-STAT3, STAT3, Bax 蛋白水平。 |
| 体内活性 | 方法:13 周龄雄性 SOD1-G93A 小鼠腹腔注射 Niclosamide (20 mg/kg 或 50 mg/kg),每日一次,直至终末期(约 160 天)。 |
| 激酶实验 | Protein Kinase profiling assay: Assay for 22 different proteins kinases is carried out by ProQinase Gmbh. All of the protein kinases are expressed either in Sf9 insect cells or in E.coli as recombinant GST-fusion proteins or His-tagged proteins. Protein kinases are purified by affinity chromatography using either GSH-agarose or Ni_NTH-agarose. A radiometric protein kinase assay is used for measuring the kinase activity of the 22 protein kinases. Briefly, for each protein kinase, 50 μL reaction cocktail containing 60 mM HEPES-NaOH, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na-orthovanadate, 1.2 mM DTT, 50 μg/mL PEG20000, 1 μM [γ-33P]-ATP, Niclosamide, adequate amount of enzyme and its substrate. The PKC-alpha assay additionally contain 1 mM Cacl2, 4 mM EDTA, 5 μg/mL phosphatidylserine and 1 μg/mL 1, 2-Dioleyl-glycerol. The reaction cocktails are incubated at 37 °C for 60 minutes and stop with 50 μL 2% (v/v) H3PO4. Incorporation of 33Pi is determined with a microplate scintillation counter. The activities and the IC50 values are calculated using Quattro Workflow V2.28. |
| 细胞实验 | Cells are plated in 96-well culture plates with cell density of 3-4 × 103 cells/well and treat with Niclosamide by adding 100 μL medium containing Niclosamide of various concentrations on the second day. After 72-hour's treatment, MTT is added to each well and incubated for additional 4-5 hours, and the absorbance is measured on a microplate reader at 570 nM. Cell growth inhibition is evaluated as the ratio of the absorbance of the sample to that of the control. The results are representative of at least 3 independent experiments. (Only for Reference) |
| 别名 | 氯硝柳胺, Niclocide, BAY2353 |
| 分子量 | 327.12 |
| 分子式 | C13H8Cl2N2O4 |
| CAS No. | 50-65-7 |
| Smiles | C(NC1=C(Cl)C=C(N(=O)=O)C=C1)(=O)C2=C(O)C=CC(Cl)=C2 |
| 密度 | 1.6646 g/cm3 (Estimated) |
| 存储 | Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | ||||||||||||||||||||
| 溶解度信息 | DMSO: 6.25 mg/mL (19.11 mM), Sonication is recommended. | ||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 0.63 mg/mL (1.93 mM), Solution. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | |||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多